The overall frequency of MDM2 gene amplification in human cancers is around 7%; however, cancer tissues such as osteosarcoma (16%), soft tissue tumors (31%), hepatocellular carcinoma (44%) and Hodgkin disease (67%) have the higher frequencies of MDM2 gene amplification [76]. Here, MDM2 is linked to osteosarcoma.